UMB’s multimedia campaign, launched in spring 2025, highlights why continued public investment in research is essential and urgent.
Category - Innovation and Discovery Archives
UMB’s multimedia campaign, launched in spring 2025, highlights why continued public investment in research is essential and urgent.
Jacques Ravel, PhD, is director of the center, which launched in March.
A $1 million gift from Maurice N. Reid, MD ’99, turns the decades-old lab into a state-of-the-art learning facility.
The School of Medicine takes another important step forward in addressing the shortage of donor hearts.
The Edward and Jennifer St. John Center for Translational Engineering and Medicine will foster collaboration between clinicians and engineers.
4MLK is the latest expression of UMB’s vision for an inclusive innovation ecosystem that brings academic discovery to life in real-world settings.
The center supported 70 research grants totaling $110 million between 2020 and 2024.
Academic expertise and real-world consulting allow the center to bridge the gap between legal theory and practical implementation of emerging technologies.
In Michael Greenberger's 22-year tenure, the center grew from a one-person operation into a nationally recognized institution with 35 professionals.
Currently, the only option is to treat infected babies with IV fluids and antibiotics.
The groundbreaking new program is believed to be the first of its kind in the world.
Joga Gobburu, a School of Pharmacy professor, is a world-renowned scientist known for transforming the field of translational medicine.
Luana Colloca, professor at the School of Nursing, has conducted groundbreaking studies on the placebo phenomenon.
The number of seriously ill children is expected to grow, emphasizing the need to develop systems and processes of care to bolster family strengths.
The division will include a multidisciplinary team of faculty, postdoctoral researchers, and doctoral and dental students.
The School of Medicine has received a $29 million research award over four years from the National Institutes of Health to lead a multicenter trial.